This is the characteristic presentation of acute pancreatitis
The majority (56%) of patients prescribed the GLP-1 drugs approved for T2DM did not have evidence of T2DM in their medical record
Class B GPCRs, including receptors for GLP-1, glucagon, GIP, PTH, calcitonin, and secretin, share a distinctive two-domain architecture
When you eat, Retatrutide enhances insulin release while suppressing glucagon (a hormone that raises blood sugar), leading to better glucose control throughout the day
Patients: A total of 1089 insulin-nave adult patients with T2D inadequately controlled on metformin alone (48%) or in combination with sulfonylurea (51%) were randomized to receive once-weekly Ozempic injection 0.5 mg (n=362), once-weekly Ozempic injection 1 mg (n=360), or once-daily insulin glargine U-100 (n=360)
doi: 10.14336/AD.2025.1165